Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion type Assertion NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_head.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion description "[While most medulloblastoma samples expressed CD133 and LIN28, OCT4 expression was found to be more sporadic, with detectable levels occurring in 48% of tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_provenance.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion evidence source_evidence_literature NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_provenance.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion SIO_000772 21725800 NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_provenance.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion wasDerivedFrom befree-20150227 NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_provenance.
- NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_assertion wasGeneratedBy ECO_0000203 NP807861.RAHELDtaPC-avCd5RxbWRQfxJL_YZD3SQFeS9NKZQ9PWE130_provenance.